Upon treatment with the EZH2 inhibitor UNC1999 in MM cell lines, the enrichment of EZH2 and H3K27me3 mark at the analyzed regions were reduced (Figure 3C and Supplementary Figure 4B). The gene discussed is EZH2; the disease is Miyoshi myopathy.